Bioavailability Studies

Amount of a substance that becomes available (reaches the target organ or systemic circulation) to an organism's body for bioactivity when introduced through ingestion, inhalation, injection, or skin contact. Rate of bioavailability depends on factors such as the type of the substance and the composition of diet.

By analyzing global market trends with data from 2012 and 2013 projections of compound annual growth rates (CAGRs) through 2018.The North American market is expected to reach around $79 billion in 2017 and is expected to raise at a 7.9% compound annual growth rate to nearly $108 billion in 2020.

  • Bioavailability of Liposomes
  • Prodrugs
  • Oral drugs
  • Therapeutic systems
  • Liposomal drug delivery

Related Conference of Bioavailability Studies

Bioavailability Studies Conference Speakers